[Proceedings: Consumption coagulopathy and hyperfibrinolysis (author's transl)].
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008833:Microcirculation; D012769:Shock / Q000150:complications
D000933:Antifibrinolytic Agents; D006493:Heparin
Verbrauchskoagulopathie und Hyperfibrinolyse.